Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA), shared a post on X:
“It was an honor to speak at JPM26 this week. We have an ambitious agenda for this year:
- Make more drugs available over-the-counter. No one likes to visit the ER for a nausea medication
- Continue to streamline the drug development process
- Modernize pathways for revolutionary cell and gene therapies
- Use more big data for post-market surveillance
- Eliminate the GRAS loophole.”
More from Marty Makary on OncoDaily.
